Area of research
Neurology · Pathology and Forensic Medicine
Research interest
Research interests include Peripheral Neuropathies and Disorders, Multiple Sclerosis Research Studies, Autoimmune Neurological Disorders and Treatments, and Myasthenia Gravis and Thymoma.
Autoimmune encephalitis: what the radiologist needs to know
Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity—a potential diagnostic pitfall in patients with MOG-EM/MOGAD
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma
Hippocampal epileptogenesis in autoimmune encephalitis
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung
Cerebrospinal fluid analysis and the determination of oligoclonal bands
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment